Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:07 pm Purchase |
2022-12-31 | 13G | Cresco Labs Inc. CRLBF |
EMINENCE CAPITAL LLC | 17,753,792 6.300% |
17,753,792 (New Position) |
Filing History |
| 2024-11-14 4:32 pm Sale |
2024-09-30 | 13G | Cresco Labs Inc. CRLBF |
NOMURA HOLDINGS INC | 16,592,116 5.000% |
-7,706,070 (-31.71%) |
Filing History |
| 2024-02-16 4:33 pm Purchase |
2024-02-09 | 13D | Cresco Labs Inc. CRLBF |
Cresco Labs Inc. | 269,739,574 20.000% |
2,312,184 (+0.86%) |
Filing |
| 2024-02-16 4:28 pm Sale |
2024-02-09 | 13D | Cresco Labs Inc. CRLBF |
Cresco Labs Inc. | 267,427,390 19.900% |
-6,324,619 (-2.31%) |
Filing |
| 2024-02-16 4:22 pm Sale |
2024-02-16 | 13G | Cresco Labs Inc. CRLBF |
Cresco Labs Inc. | 273,752,009 20.200% |
-134,011,000 (-32.86%) |
Filing |
| 2024-02-14 5:42 pm Purchase |
2024-02-14 | 13G | Cresco Labs Inc. CRLBF |
Cresco Labs Inc. | 407,763,009 30.200% |
207,471,445 (+103.58%) |
Filing |
| 2024-02-14 5:34 pm Sale |
2024-02-14 | 13G | Cresco Labs Inc. CRLBF |
Cresco Labs Inc. | 200,291,564 14.900% |
-772,826 (-0.38%) |
Filing |
| 2024-02-14 5:26 pm Purchase |
2024-02-14 | 13G | Cresco Labs Inc. CRLBF |
Cresco Labs Inc. | 201,064,390 15.000% |
201,064,390 (New Position) |
Filing |
| 2024-02-14 10:49 am Purchase |
2023-12-31 | 13G | Cresco Labs Inc. CRLBF |
NOMURA HOLDINGS INC | 24,298,186 7.600% |
24,298,186 (New Position) |
Filing History |
| 2024-02-02 12:18 pm Sale |
2023-12-29 | 13G | Cresco Labs Inc. CRLBF |
Cowen Financial Products LLC | 0 0.000% |
-19,170,307 (Position Closed) |
Filing |
| 2023-01-23 3:33 pm Purchase |
2022-12-30 | 13G | Cresco Labs Inc. CRLBF |
Cowen Financial Products LLC | 19,170,307 6.820% |
5,023,971 (+35.51%) |
Filing |
| 2022-02-14 5:30 pm Purchase |
2021-12-31 | 13G | Cresco Labs Inc. CRLBF |
Sampson Robert M | 200,680,159 15.500% |
200,680,159 (New Position) |
Filing |
| 2022-02-14 5:08 pm Purchase |
2021-12-31 | 13G | Cresco Labs Inc. CRLBF |
Bachtell Charles Ian | 405,891,486 31.200% |
405,891,486 (New Position) |
Filing |
| 2022-02-14 5:05 pm Purchase |
2021-12-31 | 13G | Cresco Labs Inc. CRLBF |
Sergi Dominic | 200,000,000 15.400% |
200,000,000 (New Position) |
Filing |
| 2022-01-20 4:06 pm Purchase |
2021-12-31 | 13G | Cresco Labs Inc. CRLBF |
Cowen Financial Products LLC | 14,146,336 5.590% |
5,284,718 (+59.64%) |
Filing |
| 2021-03-31 3:55 pm Purchase |
2021-03-25 | 13G | Cresco Labs Inc. CRLBF |
Cowen Financial Products LLC | 8,861,618 5.001% |
8,861,618 (New Position) |
Filing |